Daniel Hume
DirectoratTG Therapeutics· In proxies 2023–2025
Daniel Hume sits on 5 public boards.
Experience
- TG TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +634%
- Insight Digital Partners IIPublic company
- Director? – PresentNo stock prices for these years
- Lirum TherapeuticsPublic company
- Director? – PresentNo stock prices for these years
- for Lirum TherapeuticsPublic company
- Director? – PresentNo stock prices for these years
- National Holdings CorporationPublic company
- Director? – PresentNo stock prices for these years
- Stemline Therapeutics Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?